Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
241 Leser
Artikel bewerten:
(0)

Perfusion System Market, 2025 - Focus on Hypothermic Machine Perfusion, Normothermic Machine Perfusion

DUBLIN, June 27, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Perfusion System Market Analysis By Technology (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Organ Type (Heart, Lung, Kidney, Liver), And Segment Forecasts, 2014 - 2025" report to their offering.

Research and Markets Logo

The global perfusion systems market is expected to reach USD 183.8 million by 2025

Rising demand for transplantation owing to increased incidence of vital organ failures is a major growth driver of the market. To curb this problem, Machine Perfusion (MP) is adopted by clinics. Hence, demand for the same is expected to grow over the coming years.

Statistics published by the National Kidney Foundation in 2014 states that 4,761 patients died due to unavailability of a kidney. This showcases the need for viable donated organs for transplantation, thereby boosting market growth.

The introduction of technologically advanced products for the purpose of enhanced efficiency and cost-effectiveness is expected to serve this market with lucrative opportunities. For instance, introduction of portable organ perfusion systems is presumed to gain popularity over the coming years owing to associated benefits with its usage such as ease of access, cost-efficiency, and portability.

Market participants are involved in extensive R&D for development of innovative perfusion techniques. For instance, TransMedics, Inc. carried out the world's first warm blood perfusion liver transplantation with its innovative TransMedics Organ Care System Liver technology.

Moreover, many of market players in the U.S. and Europe are involved in the development of new products that are in clinical trials. For example, METRA developed by OrganOx Ltd. for automatic liver transportation and normothermic liver perfusion is under clinical study in the U.S. The expected product approvals in the coming years are anticipated to serve this industry with lucrative growth opportunities.

Key Topics Covered:

1 Research Methodology

2 Executive Summary

3 Organ Perfusion Systems Market Variables, Trends & Scope

4 Organ Perfusion Systems: Technology Estimates & Trend Analysis

5 Organ Perfusion Systems: Organ Type Estimates & Trend Analysis

6 Organ Perfusion Systems: Regional Estimates & Trend Analysis, by Technology, and Organ Type

7 Competitive Landscape

  • XVIVO Perfusion AB
  • Organ Assist B.V.
  • Organ Recovery Systems, Inc
  • Organ Transport Systems, Inc.
  • Waters Medical Systems LLC
  • Paragonix Technologies, Inc.
  • TransMedics, Inc.
  • OrganOx Limited
  • Preservation Solutions Inc
  • Bridge to Life Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/89m9ng/perfusion_system

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.